Package Leaflets (PL) for Human medicinal products

The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.

The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.

The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Product Information Leaflets 151 - 180 of 265
<  Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >
SPC	Status for supply	Name of the medicinal product
		European Medicines Agency's website: Ritonavir Mylan - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Ritonavir Sandoz 100 mg tabletti PL 2020-05-06
		European Medicines Agency's website: Rivaroxaban Accord - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Rivaroxaban Avansor 10 mg tabletti, kalvopäällysteinen PL 2021-10-26
SPC	Resepti	Rivaroxaban Avansor 15 mg, 20 mg tabletti, kalvopäällysteinen PL 2021-10-26
SPC	Resepti	Rivaroxaban Avansor 2,5 mg tabletti, kalvopäällysteinen PL 2021-10-26
SPC	Resepti	Rivaroxaban Krka 10 mg tabletti, kalvopäällysteinen PL 2024-03-13
SPC	Resepti	Rivaroxaban Krka 15 mg, 20 mg tabletti, kalvopäällysteinen PL 2024-03-13
SPC	Resepti	Rivaroxaban Krka 2,5 mg tabletti, kalvopäällysteinen PL 2024-03-13
SPC	Resepti	Rivaroxaban Orion 10 mg tabletti, kalvopäällysteinen PL 2023-08-25
SPC	Resepti	Rivaroxaban Orion 15 mg, 20 mg tabletti, kalvopäällysteinen PL 2023-08-25
SPC	Resepti	Rivaroxaban Orion 2.5 mg tabletti, kalvopäällysteinen PL 2023-08-25
SPC	Resepti	Rivaroxaban ratiopharm 10 mg tabletti, kalvopäällysteinen PL 2023-12-20
SPC	Resepti	Rivaroxaban ratiopharm 15 mg, 20 mg tabletti, kalvopäällysteinen PL 2023-12-20
SPC	Resepti	Rivaroxaban ratiopharm 15 mg, 20 mg tabletti, kalvopäällysteinen PL 2023-12-20 aloituspakkaus
SPC	Resepti	Rivaroxaban ratiopharm 2,5 mg tabletti, kalvopäällysteinen PL 2023-12-20
SPC	Resepti	Rivaroxaban Sandoz 10 mg tabletti, kalvopäällysteinen PL 2024-02-06
SPC	Resepti	Rivaroxaban Sandoz 15 mg, 20 mg tabletti, kalvopäällysteinen PL 2024-02-06
SPC	Resepti	Rivaroxaban Sandoz 2,5 mg tabletti, kalvopäällysteinen PL 2024-02-06
SPC	Resepti	Rivaroxaban Stada 10 mg tabletti, kalvopäällysteinen PL 2023-08-23
SPC	Resepti	Rivaroxaban Stada 15 mg + 20 mg tabletti, kalvopäällysteinen PL 2023-08-23
SPC	Resepti	Rivaroxaban Stada 15 mg, 20 mg kapseli, kova hoidon aloituspakkaus PL 2023-08-16
SPC	Resepti	Rivaroxaban Stada 15 mg, 20 mg kapseli, kova PL 2023-08-16
SPC	Resepti	Rivaroxaban Stada 15 mg, 20 mg tabletti, kalvopäällysteinen PL 2023-08-23
SPC	Resepti	Rivaroxaban Stada 2,5 mg tabletti, kalvopäällysteinen PL 2023-08-23
		European Medicines Agency's website: Rivaroxaban Viatris (ent. Rivaroxaban Mylan) - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Rivastigmin Orion 1,5 mg, 3 mg, 4,5 mg, 6 mg kapseli, kova PL 2023-07-04
SPC	Resepti	Rivastigmin Stada 1.5 mg, 3 mg, 4.5 mg, 6 mg kapseli, kova PL 2022-07-26
		European Medicines Agency's website: Rivastigmine 1 A Pharma - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Rivastigmine Actavis - EMA: EPAR PI Finnish Swedish
<  Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >